Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.
about
Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapyUsefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic reviewThe value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?Detection of alterations in membrane metabolism during neoadjuvant chemotherapy in patients with breast cancer using phosphorus magnetic resonance spectroscopy at 7 Tesla.Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CTEffect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis.Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimenFeasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast CancerDisease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysisValue of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese PopulationAxillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancerComparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with opValue of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin.Current approaches for neoadjuvant chemotherapy in breast cancer.Three-dimensional Contrast-enhanced Ultrasound in Response Assessment for Breast Cancer: A Comparison with Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathology.Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy.Nanoparticle albumin-bound paclitaxel in a patient with locally advanced breast cancer and taxane-induced skin toxicity: a case report.Arterial input functions in dynamic contrast-enhanced magnetic resonance imaging: which model performs best when assessing breast cancer response?A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancerSurgical considerations in patients receiving neoadjuvant systemic therapy.Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer.Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.Role of imaging in neoadjuvant therapy for breast cancer.A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
P2860
Q33573055-9D1A6E4A-F413-4CA5-8AF0-BE72EB4E5D48Q33599465-7D89B23D-C152-4039-B227-04A4715F4517Q33706962-CA55796A-9E53-4A79-96F0-993D5D3B331BQ33889349-3CC0B970-6D2F-4840-B161-FFE9AC1ED8D5Q34051790-5A76891A-BFCE-43BF-80F6-EAEBC724C13CQ34140986-CF44F2C3-5F30-4968-998E-0AD4E11AAE47Q34566213-95FF7516-A297-48A8-848E-E4FC80122E65Q34690824-FB66EA98-CE28-4A5A-9226-07EB40104B0AQ34779690-7036F88A-B82C-400F-9508-5B20F1B881C7Q35155635-7605CDB0-0F7E-49B2-8AE0-3ED614F6A28AQ35345516-C9A4E018-3E02-4595-B654-499F45222368Q35537575-BB86AD03-D03F-4CC8-A960-6BF0597009EBQ35649202-52686129-1A81-41B1-9B52-F5C100E37935Q35759050-0E1EAFF8-986C-4864-8560-ED629E9410D5Q35947118-5FF65679-B8D9-424E-A1ED-68E4E6A462EDQ35948773-71AD47B6-DE63-4216-B51F-8CE4B57C0C10Q36084852-E9592C67-8298-48D5-A36E-5413368A8074Q36150390-3C35975A-20FD-4172-9848-5CD5FEA51B53Q36245392-4C29CAE9-F849-488F-ACE2-B8CF8BD64DF7Q36284245-33739134-273C-415D-877D-5C3B30F1FD60Q36891801-830AC90D-DD93-48BB-92C3-F92C170A8E37Q36897778-05847578-74B0-477B-99A0-BB6AA94E0715Q37003825-AB4E30CD-2DB7-4E46-A5F1-C5743DF9FFDBQ37101590-D02DAD1D-6812-4924-AE9B-C8128A398314Q37135365-7D5A6685-ACAD-4E39-ABC9-43E77C4432E9Q37274051-7D2AF7F3-9F22-4ABA-9437-AF2DECBAF230Q37289071-48536161-4512-481E-B1AD-08F2C4A59DBAQ37567063-B676CF9C-127A-42AB-B2C1-58974E691586Q37600890-0B0B3677-7C49-43F1-A5F6-E45CADB986ECQ37699422-DA71B25D-4172-41C5-A2F2-D0D047023516Q37992692-06964526-DF2B-4104-9AE7-1058A96208E9Q38068585-D7C776BE-5B1B-447C-8C4B-9CE3F6304AC1Q38157648-FB5B6015-58DA-4400-ADE7-03FCD566D422Q38269966-0289C564-346A-495A-9C18-0F97458327CEQ38317182-A2AF6D52-1718-4837-AF4F-C77A62EB426BQ38366386-C4CA3C85-00F1-4CEC-9F34-E12E2F9EC057Q38432397-25D697D3-2E01-4280-A836-D18218C89FA3Q38696564-DBEFFA66-D368-4EBE-B089-B1A11F1D5896Q38771946-2BA8922D-539F-4F21-9F5D-0A03A88B3083Q39114881-392D1594-57A2-4A72-B843-A0775EEC6815
P2860
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meta-analysis confirms achievi ...... is for breast cancer patients.
@en
Meta-analysis confirms achievi ...... is for breast cancer patients.
@nl
type
label
Meta-analysis confirms achievi ...... is for breast cancer patients.
@en
Meta-analysis confirms achievi ...... is for breast cancer patients.
@nl
prefLabel
Meta-analysis confirms achievi ...... is for breast cancer patients.
@en
Meta-analysis confirms achievi ...... is for breast cancer patients.
@nl
P2093
P921
P1476
Meta-analysis confirms achievi ...... is for breast cancer patients.
@en
P2093
Bruce Haffty
Meena S Moran
Ning Zhang
Qifeng Yang
Xiangnan Kong
P304
P356
10.1016/J.EJCA.2011.06.014
P577
2011-07-05T00:00:00Z